Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 5,789 $ 8,044
Restricted cash 312 312
Accounts receivable, less allowance of $ 2,531 and $850 in 2019 and 2018, respectively 8,760 11,112
Inventory 10,995 12,248
Prepaid expenses and other current assets 1,163 1,591
Total current assets 27,019 33,307
Property, plant, and equipment, net 1,193 1,975
Goodwill 2,926 2,926
Right of use asset 276  
Other assets 433 308
Total assets 31,847 38,516
Current liabilities:    
Accounts payable 5,332 5,953
Accrued liabilities 4,744 7,538
Deferred revenue 2,237 2,476
Term loan 13,466  
Total current liabilities 25,779 15,967
Deferred income taxes, net 78 77
Deferred revenue 358  
Warranty accrual 245 447
Other liabilities 1,045 100
Term loan   10,836
Total liabilities 27,505 27,427
Commitments and contingencies —Note 7
Redeemable preferred stock:    
Preferred stock, par value $0.001 per share; 1,000 shares authorized, 70 and 0 shares issued and outstanding as of December 31, 2019 and 2018, respectively 3,965  
Stockholders' equity:    
Common stock, par value $0.001 per share; 40,000 and 40,000 shares authorized, 31,439 and 21,972, shares issued and outstanding as of December 31, 2019 and 2018, respectively 31 21
Additional paid-in capital 235,594 228,430
Accumulated other comprehensive loss (701) (670)
Accumulated deficit (234,547) (216,692)
Total stockholders' equity 377 11,089
Total liabilities, redeemable preferred stock and stockholders' equity $ 31,847 $ 38,516